Department of Medical Microbiology and Infection Control, Amsterdam Infection and Immunity Institute, Amsterdam UMC, Vrije Universiteit Amsterdam, PK 2X132, De Boelelaan 1117, Amsterdam, The Netherlands.
Center for Infectious Diseases, Department of Medical Microbiology, Leiden University Medical Center, Albinusdreef 2, Leiden, The Netherlands.
Antimicrob Resist Infect Control. 2021 Jan 29;10(1):23. doi: 10.1186/s13756-020-00881-9.
Clostridioides difficile is the most common cause of nosocomial diarrhea. Ribotyping of cultured strains by a PCR-based test is used to study potential transmission between patients. We aimed to develop a rapid test that can be applied directly on fecal samples for simultaneous detection and ribotyping of C. difficile, as well as detection of toxin genes.
We developed a highly specific and sensitive primer set for simultaneous detection and ribotyping of C. difficile directly on total fecal DNA. Toxin genes were detected with primers adapted from Persson et al. (Clin Microbiol Infect 14(11):1057-1064). Our study set comprised 130 fecal samples: 65 samples with positive qPCR for C. difficile toxin A/B genes and 65 C. difficile qPCR negative samples. PCR products were analyzed by capillary gel electrophoresis.
Ribosomal DNA fragment peak profiles and toxin genes were detected in all 65 C. difficile positive fecal samples and in none of the 65 C. difficile negative samples. The 65 samples were assigned to 27 ribotypes by the Dutch reference laboratory. Our peak profiles corresponded to these ribotypes, except for two samples. During a C. difficile outbreak, patients were correctly allocated to the outbreak-cluster based on the results of direct fecal ribotyping, before C. difficile isolates were cultured and conventionally typed.
C. difficile ribotyping directly on fecal DNA is feasible, with sensitivity and specificity comparable to that of diagnostic toxin gene qPCR and with ribotype assignment similar to that obtained by conventional typing on DNA from cultured isolates. This supports simultaneous diagnosis and typing to recognize an outbreak.
艰难梭菌是医院获得性腹泻最常见的病因。基于聚合酶链反应(PCR)的培养菌株核糖体分型技术用于研究患者之间的潜在传播。我们旨在开发一种直接应用于粪便样本的快速检测方法,用于同时检测和核糖体分型艰难梭菌,以及检测毒素基因。
我们开发了一套高特异性和高灵敏度的引物,用于直接在总粪便 DNA 上同时检测和核糖体分型艰难梭菌。毒素基因的检测使用了 Persson 等人(Clin Microbiol Infect 14(11):1057-1064)改编的引物。我们的研究集包括 130 份粪便样本:65 份粪便样本的 qPCR 检测为艰难梭菌毒素 A/B 基因阳性,65 份粪便样本的 qPCR 检测为艰难梭菌阴性。PCR 产物通过毛细管凝胶电泳进行分析。
在所有 65 份艰难梭菌阳性粪便样本中均检测到核糖体 DNA 片段峰谱和毒素基因,在 65 份艰难梭菌阴性粪便样本中均未检测到。荷兰参考实验室将这 65 个样本分配到 27 个核糖体型中。我们的峰谱与这些核糖体型相对应,除了两个样本。在一次艰难梭菌暴发期间,在培养和常规分型艰难梭菌分离株之前,直接对粪便进行核糖体分型可以正确地将患者分配到暴发集群中。
直接在粪便 DNA 上进行艰难梭菌核糖体分型是可行的,其敏感性和特异性与诊断性毒素基因 qPCR 相当,并且与从培养分离株的 DNA 获得的常规分型的核糖体型分配相似。这支持同时进行诊断和分型以识别暴发。